MedPath

Comparison of aspirin with rivaroxaban for prevention deep venous thrombosis after total knee arthroplasty.

Phase 4
Completed
Conditions
Deep vein thrombosis
Total knee arthroplasty
Registration Number
TCTR20201226005
Lead Sponsor
Faculty of Medicine, Prince of Songkla University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
40
Inclusion Criteria

primary knee osteoarthritis
older than 50-year-old
receive total knee arthroplasty

Exclusion Criteria

coagulopathy,
history of venous thromboembolism
on an anticoagulant, azole group, and proteinase inhibitor
allergic to medication in this study
allergic to contrast material for computer tomography
severe chronic kidney disease
cirrhosis
asthma.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Deep vein thrombosis Post operative day 4, 14 Ultrasonography,Deep vein thrombosis Post operative day 4, 14 Ultrasonography
Secondary Outcome Measures
NameTimeMethod
Hematocrit Post operative 6 hour, 25 hour Blood hematocrit level
© Copyright 2025. All Rights Reserved by MedPath